Stocks and Investing Stocks and Investing
Fri, September 11, 2020
Thu, September 10, 2020
Wed, September 9, 2020
Tue, September 8, 2020
Fri, September 4, 2020
Thu, September 3, 2020
Wed, September 2, 2020

Chris Howerton Initiated (BTAI) at Strong Buy and Held Target at $82 on, Sep 2nd, 2020


Published on 2024-10-27 12:55:59 - WOPRAI, Chris Howerton
  Print publication without navigation


Chris Howerton of Jefferies, Initiated "BioXcel Therapeutics, Inc." (BTAI) at Strong Buy and Held Target at $82 on, Sep 2nd, 2020.

Chris has made no other calls on BTAI in the last 4 months.



There are 2 other peers that have a rating on BTAI. Out of the 2 peers that are also analyzing BTAI, 0 agree with Chris's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Chris


  • Raghuram Selvaraju of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $175 on, Monday, August 17th, 2020
  • Geoff Meacham of "B of A Securities" Reiterated at Strong Buy with Increased Target to $63 on, Monday, July 13th, 2020